An Open Label Extension Study of Duloxetine (LY248686) in Participants With Chronic Low Back Pain
PHASE3
The purpose of the study is to assess the long term safety of duloxetine in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
PHASE4
This study investigates two different approaches to the change in antidepre...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
PHASE3
The purpose of this study is to assess whether duloxetine is superior to pl...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
PHASE3
The purpose of this study is to compare the efficacy and safety of switchin...